Stock Analysis

Acuity RM Group Full Year 2023 Earnings: UK£0.014 loss per share (vs UK£0.008 loss in FY 2022)

AIM:ACRM
Source: Shutterstock

Acuity RM Group (LON:ACRM) Full Year 2023 Results

Key Financial Results

  • Revenue: UK£1.37m (up by UK£1.31m from FY 2022).
  • Net loss: UK£1.34m (loss widened by 293% from FY 2022).
  • UK£0.014 loss per share (further deteriorated from UK£0.008 loss in FY 2022).
earnings-and-revenue-history
AIM:ACRM Earnings and Revenue History June 17th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Acuity RM Group shares are down 3.8% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 5 warning signs for Acuity RM Group (2 make us uncomfortable) you should be aware of.

Valuation is complex, but we're helping make it simple.

Find out whether Acuity RM Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're helping make it simple.

Find out whether Acuity RM Group is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com